• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

发现新型喹唑啉类化合物作为潜在的抗微管蛋白剂,占据秋水仙碱结构域的三个区域。

Discovery of novel quinazolines as potential anti-tubulin agents occupying three zones of colchicine domain.

机构信息

State Key Laboratory of Natural Medicines and Department of Medicinal Chemistry, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing 210009, PR China.

Department of Organic Chemistry, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing 210009, PR China; State Key Laboratory for the Chemistry and Molecular Engineering of Medicinal Resources, and School of Chemistry and Pharmacy, Guangxi Normal University, Guilin 541004, PR China.

出版信息

Bioorg Chem. 2019 Mar;83:380-390. doi: 10.1016/j.bioorg.2018.10.027. Epub 2018 Oct 23.

DOI:10.1016/j.bioorg.2018.10.027
PMID:30408650
Abstract

A series of novel quinazolines as tubulin inhibitors occupying three zones of colchicine domain have been designed and synthesized inspired by the recently disclosed crystal structure of verubulin analogue 6 with tubulin. Among the newly synthesized compounds, 19c showed noteworthy potency against K562, HepG2, KB, HCT-8 and MDB-MB-231 cancer cells. In vitro microtubule polymerization assays identified 19c as a potent tubulin assembly inhibitor, the binding mode of which with tubulin was confirmed by molecular modeling studies to occupy three zones of tubulin domain. Furthermore, 19c disrupted the intracellular microtubule network, caused G2/M phase arrest, induced cell apoptosis and depolarized mitochondria of K562 cells. 19c also reduced the cell migration and disrupted the capillary-like tube formation of human umbilical vein endothelial cells (HUVECs). Importantly, 19c significantly and dose dependently inhibited tumor growth in H22 liver cancer xenograft mouse model. All these results suggested that 19c deserves further research as a novel and potential anti-tubulin agent for the treatment of cancers.

摘要

受最近公开的与微管蛋白结合的长春瑞滨类似物 6 的晶体结构的启发,设计并合成了一系列新型喹唑啉类化合物,作为占据秋水仙碱结构域三个区域的微管蛋白抑制剂。在所合成的新化合物中,化合物 19c 对 K562、HepG2、KB、HCT-8 和 MDB-MB-231 癌细胞表现出显著的活性。体外微管聚合实验鉴定出 19c 是一种有效的微管蛋白组装抑制剂,其与微管蛋白的结合模式通过分子建模研究得到证实,可占据微管蛋白结构域的三个区域。此外,19c 破坏了细胞内的微管网络,导致 G2/M 期停滞,诱导细胞凋亡和 K562 细胞线粒体去极化。19c 还减少了细胞迁移并破坏了人脐静脉内皮细胞(HUVEC)的毛细血管样管状形成。重要的是,19c 显著且剂量依赖性地抑制了 H22 肝癌异种移植小鼠模型中的肿瘤生长。所有这些结果表明,19c 值得进一步研究,作为一种新型潜在的抗微管蛋白药物,用于癌症治疗。

相似文献

1
Discovery of novel quinazolines as potential anti-tubulin agents occupying three zones of colchicine domain.发现新型喹唑啉类化合物作为潜在的抗微管蛋白剂,占据秋水仙碱结构域的三个区域。
Bioorg Chem. 2019 Mar;83:380-390. doi: 10.1016/j.bioorg.2018.10.027. Epub 2018 Oct 23.
2
Synthesis, molecular properties prediction and biological evaluation of indole-vinyl sulfone derivatives as novel tubulin polymerization inhibitors targeting the colchicine binding site.合成、分子性质预测及吲哚-乙烯砜衍生物作为新型微管聚合抑制剂的生物评价:以秋水仙碱结合位点为靶点。
Bioorg Chem. 2019 Apr;85:49-59. doi: 10.1016/j.bioorg.2018.12.015. Epub 2018 Dec 10.
3
Design, synthesis and anticancer properties of IsoCombretaQuinolines as potent tubulin assembly inhibitors.异康布雷他喹啉作为有效的微管蛋白组装抑制剂的设计、合成及抗癌特性
Eur J Med Chem. 2017 Feb 15;127:1025-1034. doi: 10.1016/j.ejmech.2016.11.012. Epub 2016 Nov 9.
4
Synthesis and biological evaluation of novel shikonin-benzo[b]furan derivatives as tubulin polymerization inhibitors targeting the colchicine binding site.新型紫草素-苯并[b]呋喃衍生物的合成及作为靶向秋水仙碱结合位点的微管蛋白聚合抑制剂的生物评价。
Eur J Med Chem. 2020 Mar 15;190:112105. doi: 10.1016/j.ejmech.2020.112105. Epub 2020 Jan 28.
5
Design, synthesis and biological evaluation of a novel tubulin inhibitor SKLB0565 targeting the colchicine binding site.新型微管蛋白抑制剂 SKLB0565 靶向秋水仙素结合位点的设计、合成与生物评价。
Bioorg Chem. 2020 Apr;97:103695. doi: 10.1016/j.bioorg.2020.103695. Epub 2020 Feb 24.
6
Synthesis and biological evaluation of quinoxaline derivatives as tubulin polymerization inhibitors that elevate intracellular ROS and triggers apoptosis via mitochondrial pathway.合成并评价作为微管聚合抑制剂的喹喔啉衍生物,通过线粒体途径升高细胞内 ROS 并触发细胞凋亡。
Chem Biol Drug Des. 2019 Apr;93(4):617-627. doi: 10.1111/cbdd.13459. Epub 2019 Jan 11.
7
Design, synthesis and anticancer properties of isocombretapyridines as potent colchicine binding site inhibitors.异卡梅啶并吡啶类化合物的设计、合成及作为强力秋水仙碱结合位点抑制剂的抗癌活性。
Eur J Med Chem. 2020 Jul 1;197:112308. doi: 10.1016/j.ejmech.2020.112308. Epub 2020 Apr 19.
8
Synthesis and biological evaluation of substituted N-(2-(1H-benzo[d]imidazol-2-yl)phenyl)cinnamides as tubulin polymerization inhibitors.取代的 N-(2-(1H-苯并[d]咪唑-2-基)苯基)肉桂酰胺类化合物的合成及作为微管蛋白聚合抑制剂的生物评价。
Bioorg Chem. 2020 Oct;103:104191. doi: 10.1016/j.bioorg.2020.104191. Epub 2020 Aug 26.
9
Design, synthesis and biological evaluation of a novel tubulin inhibitor 7a3 targeting the colchicine binding site.新型微管蛋白抑制剂 7a3 的设计、合成与生物评价及其与秋水仙碱结合部位的靶向作用。
Eur J Med Chem. 2018 Aug 5;156:162-179. doi: 10.1016/j.ejmech.2018.05.010. Epub 2018 May 10.
10
Design, synthesis, and evaluation of new 2-oxoquinoline arylaminothiazole derivatives as potential anticancer agents.设计、合成和评价新型 2-氧代喹啉芳氨基噻唑衍生物作为潜在的抗癌剂。
Bioorg Chem. 2021 Jan;106:104469. doi: 10.1016/j.bioorg.2020.104469. Epub 2020 Nov 10.

引用本文的文献

1
Potential of Using New Indole- and Benzimidazo[1,2-C]quinazolines in Anticancer Therapy Based on Mesenchymal Stem Cells.基于间充质干细胞的新型吲哚和苯并咪唑并[1,2-c]喹唑啉在抗癌治疗中的应用潜力
Cancer Manag Res. 2025 Jun 11;17:1087-1097. doi: 10.2147/CMAR.S516593. eCollection 2025.
2
Synthesis and screening of novel 2,4-bis substituted quinazolines as tubulin polymerization promoters and antiproliferative agents.新型2,4-双取代喹唑啉作为微管蛋白聚合促进剂和抗增殖剂的合成与筛选
RSC Med Chem. 2025 Jan 15. doi: 10.1039/d4md00755g.
3
Quinazoline Derivatives as Targeted Chemotherapeutic Agents.
喹唑啉衍生物作为靶向化疗药物。
Cureus. 2024 May 20;16(5):e60662. doi: 10.7759/cureus.60662. eCollection 2024 May.
4
β-Enaminonitrile in the synthesis of tetrahydrobenzo[]thiophene candidates with DFT simulation, antiproliferative assessment, molecular docking, and modeling pharmacokinetics.通过密度泛函理论模拟、抗增殖评估、分子对接和药代动力学建模,利用β-烯胺腈合成四氢苯并[]噻吩候选物
RSC Adv. 2024 Jun 10;14(26):18417-18430. doi: 10.1039/d4ra03363a. eCollection 2024 Jun 6.
5
Verubulin (Azixa) Analogues with Increased Saturation: Synthesis, SAR and Encapsulation in Biocompatible Nanocontainers Based on Ca or Mg Cross-Linked Alginate.饱和度增加的维鲁布林(阿齐萨)类似物:基于钙或镁交联藻酸盐的生物相容性纳米容器中的合成、构效关系及包封
Pharmaceuticals (Basel). 2023 Oct 21;16(10):1499. doi: 10.3390/ph16101499.
6
Avermectin B1a Shows Potential Anti-Proliferative and Anticancer Effects in HCT-116 Cells via Enhancing the Stability of Microtubules.阿维菌素B1a通过增强微管稳定性对HCT-116细胞显示出潜在的抗增殖和抗癌作用。
Curr Issues Mol Biol. 2023 Jul 27;45(8):6272-6282. doi: 10.3390/cimb45080395.
7
Benzotriazole Substituted 2-Phenylquinazolines as Anticancer Agents: Synthesis, Screening, Antiproliferative and Tubulin Polymerization Inhibition Activity.苯并三唑取代的 2-苯基喹唑啉类化合物作为抗癌剂:合成、筛选、抗增殖和微管蛋白聚合抑制活性。
Curr Cancer Drug Targets. 2023;23(4):278-292. doi: 10.2174/1568009623666221028121906.
8
Discovery of Simple Diacylhydrazine-Functionalized Cinnamic Acid Derivatives as Potential Microtubule Stabilizers.发现简单二酰肼功能化肉桂酸衍生物作为潜在的微管稳定剂。
Int J Mol Sci. 2022 Oct 15;23(20):12365. doi: 10.3390/ijms232012365.
9
A novel tubulin inhibitor, 6h, suppresses tumor-associated angiogenesis and shows potent antitumor activity against non-small cell lung cancers.一种新型微管蛋白抑制剂 6h,可抑制肿瘤相关血管生成,并对非小细胞肺癌显示出强大的抗肿瘤活性。
J Biol Chem. 2022 Jul;298(7):102063. doi: 10.1016/j.jbc.2022.102063. Epub 2022 May 23.
10
MSCs as Tumor-Specific Vectors for the Delivery of Anticancer Agents-A Potential Therapeutic Strategy in Cancer Diseases: Perspectives for Quinazoline Derivatives.间充质干细胞作为抗癌药物的肿瘤特异性载体——癌症疾病的潜在治疗策略:喹唑啉衍生物的展望。
Int J Mol Sci. 2022 Mar 2;23(5):2745. doi: 10.3390/ijms23052745.